官方服务：
资源简介：
Adenosine-treated endothelial progenitor cells
应用场景：
创建时间：
2011-01-29
相关数据集
Global Cell and Gene Therapy Clinical Trial Market 2023-2029
The global cell and gene therapy clinical trial market is likely to register a CAGR of over 12.3% with an incremental growth of USD 7.2 billion during the forecast period 2023-2029
www.bonafideresearch.com100
Application research of recanalization of the umbilical vein in portal vein embolization in radical hepatectomy of colorectal liver metastasis
Interventions: One group:portal vein embolization approach-recanalization of the umbilical vein Primary outcome(s): Portal vein catheter success rate Study Design: historical control
NIAID Data Ecosystem50
Cell administration routes for heart failure: a comparative re-evaluation of the REGENERATE-DCM and REGENERATE-IHD trials. Supplementary tables
Table S1. Baseline characteristics of the REGENERATE-DCM and REGENERATE-IHD trials Table S2. The characteristics of the cells found in the injectate in the individu
DataCite Commons2024-05-17 更新50
Gene expression from pericytes
Background: Blood vessel wall adventitial progenitors may yield a renewable source for therapeutic vasculogenesis in limb and myocardial ischemia models. Donor-related liabilities, epigenetic and expr
NIAID Data Ecosystem60
Mir-130a potentiates the reparative properties of human endothelial colony forming cells facing hypoxia via VEGFR2 and STAT3
Hypoxia controls reparative angiogenesis. MiRNAs are master regulators of gene expression in hypoxia and angiogenesis. However, we do not yet have a clear understanding of how hypoxia-induced miRNAs m
NIAID Data Ecosystem50
